Webinar: How People Affected by HCV & TB Feel About Potential Long-Acting Therapies

Treatment Action Group (TAG) and Afrocab will host a webinar on 30 May 2025 to share findings from surveys conducted under the Unitaid-funded LONGEVITY Project to understand HCV and TB end user and healthcare providers/policy maker preferences and attitudes towards three long-acting modalities namely: injections, implants and microarray patches (MAPs), and explore challenges and opportunities for these long-acting treatment modalities.

For full details about the webinar and to register, click here.